RecruitingPhase 3NCT04629833
Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy
Studying Best vitelliform macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- medac GmbH
- Principal Investigator
- Ann-Kristin Möllermedac GmbH
- Intervention
- MC0518(biological)
- Enrollment
- 210 target
- Eligibility
- 12 years · All sexes
- Timeline
- 2021 – 2030
Study locations (30)
- Centre Hospitalier Universitaire (CHU) Amiens-Picardie - Hopital Sud, Amiens, France
- CHU Jean Minjoz, Besançon, France
- Hopital Michallon, Grenoble, France
- CHRU Lille- Hopital Claude Huriez, Lille, France
- CHU de Nantes - Hotel Dieu, Nantes, France
- CHU de Nice Hopital Archet 1, Nice, France
- Centre Hospitalier Lyon Sud Pavillon Marcel Berard 1G, Pierre-Bénite, France
- Centre Hospitalier Universitaire CHU de Toulouse, Toulouse, France
- Hopitaux De Brabois, Vandœuvre-lès-Nancy, France
- Klinikum rechts der Isar, Munich, Bavaria, Germany
- Universitaetsklinikum Wuerzburg - Medizinische Klinik und Poliklinik II - Zentrum fuer Allogene Blutstammzelltransplantation, Würzburg, Bavaria, Germany
- Klinikum der Johann Wolfgang Goethe-Universitaet - Frankfurt am Main, Frankfurt am Main, Hesse, Germany
- Medizinische Hochschule Hannover, Hanover, Lower Saxony, Germany
- Uniklinik Koeln, Cologne, North Rhine-Westphalia, Germany
- Universitaetsklinikum Essen - Klinik fuer Knochenmarktransplantation (KMT), Essen, North Rhine-Westphalia, Germany
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04629833 on ClinicalTrials.govOther trials for Best vitelliform macular dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07171554Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal CancerOncosyne AS
- RECRUITINGNANCT07234409Clinical Trial Addressing the Best Surgical Approach for Partial Nephrectomy With Single Port Robotic System in the Management of Localized Renal Cell CarcinomaNiguarda Hospital
- RECRUITINGNANCT07281092Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)Seattle Children's Hospital
- RECRUITINGPHASE1, PHASE2NCT07185256Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)Opus Genetics, Inc
- RECRUITINGNCT06805474A Prospective Observational Study to Assess the Reliability and Validity of the MLSDTNanoscope Therapeutics Inc.
- RECRUITINGNANCT06899399Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery StenosisBeijing Tiantan Hospital
- ACTIVE NOT RECRUITINGNANCT05802940Low Dose Aspirin Alerts in High-Risk PregnanciesGeisinger Clinic
- RECRUITINGNANCT05737407Lung Ultrasound Guided Choice of Best Positive End-Expiratory Pressure in Neonatal AnesthesiaVittore Buzzi Children's Hospital